BMY logo
BMY
Bristol-Myers Squibb

Aging Demographics And Genomics Will Drive Healthcare Demand

Published
18 Jul 24
Updated
20 Aug 25
AnalystConsensusTarget's Fair Value
US$53.00
11.1% undervalued intrinsic discount
20 Aug
US$47.14
Loading
1Y
-2.0%
7D
-2.5%

Author's Valuation

US$53.0

11.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates9

Shared on07 May 25
Fair value Decreased 7.26%

Read more

Shared on30 Apr 25
Fair value Decreased 1.70%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on23 Apr 25
Fair value Decreased 1.49%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on16 Apr 25
Fair value Decreased 1.34%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on09 Apr 25
Fair value Decreased 0.63%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on02 Apr 25
Fair value Decreased 1.65%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on19 Mar 25
Fair value Increased 8.24%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on10 Mar 25
Fair value Decreased 0.96%

Read more